Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11
Closed -$1.28K 469
2023
Q1
$1.28K Hold
11
﹤0.01% 1099
2022
Q4
$1.25K Buy
11
+3
+38% +$329 ﹤0.01% 1090
2022
Q3
$1K Sell
8
-4
-33% -$339 ﹤0.01% 1076
2022
Q2
$1K Hold
12
﹤0.01% 1062
2022
Q1
$2K Sell
12
-4
-25% -$438 ﹤0.01% 387
2021
Q4
$2K Buy
+16
New +$2.3K ﹤0.01% 346

Other funds holding DXCM

Schubert & Co's DXCM Position: Q2 2023 in Review

Schubert & Co sold out of DexCom (DXCM) in Q2 2023, closing a stake of 11 shares — an estimated $1.28K sold.

Schubert & Co first reported a position in DXCM in Q4 2021 and held it in 6 quarters. The position peaked at $2K in Q1 2022. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • Schubert & Co reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 11 DexCom shares in Q2 2023, an estimated $1.28K.
  • Schubert & Co first reported a position in DexCom in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's DexCom position peaked at $2K in Q1 2022.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.